Anisha Dua, MD, MPH (moderator)
Assistant Professor of Medicine
Department of Rheumatology
Fellowship Program Director
Director of the Vasculitis Center
University of Chicago
Anne R. Bass, MD
Associate Professor of Clinical Medicine
Weill Cornell Medical College
Rheumatology Fellowship Program Director
Hospital for Special Surgery
New York, NY
Jon T. Giles, MD, MPH
Associate Professor of Medicine
Division of Rheumatology
Columbia University College of Physicians and Surgeons
New York, NY
1.0 AMA PRA Category 1 Credit™
Inflammatory rheumatic diseases, including rheumatoid arthritis (RA), psoriatic arthritis (PsA), and ankylosing spondylitis (AS), have a significant negative impact on patients’ physical functioning and quality of life. This activity will examine early recognition and guideline-driven treatment for these conditions.
Rheumatologists and other clinicians who manage patients with inflammatory rheumatic diseases.
Upon completion of this educational activity, the participant should be able to:
- Describe specific clinical, laboratory, and imaging findings that can differentiate RA, PsA, and AS from each other and other similar conditions.
- Characterize RA, PsA, and AS in terms of disease severity and course.
- Review the most current evidence for a T2T approach for patients with RA, PsA, and AS.
- Discuss recent updates in RA, PsA, and AS treatment guidelines.
- Outline newly approved and investigational agents for RA, PsA, and AS that are likely to be incorporated into future standards of care for these conditions.
As a provider accredited by the ACCME, The University of Chicago Pritzker School of Medicine, asks everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. This includes any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. The ACCME defines "relevant financial relationships" as financial relationships in any amount occurring within the past 12 months including financial relationships of a spouse or life partner that could create a conflict of interest. Mechanisms are in place to identify and resolve any potential conflict of interest prior to the start of the activity.
Dr. Dua has no relevant financial relationships with any commercial interests.
Dr. Bass discloses the following conflicts of interest.
Clinical research: Pfizer, Abbott Labs
Dr. Giles discloses the following conflicts of interest.
Consultant: Genentech, Janssen
Mahira Zec Bonomo, University of Chicago, Director for CME, has nothing to disclose.
Lillian McVey, MCM Education medical writer, has nothing to disclose.
Kathleen Hines, MCM Education VP, Editorial Services, has nothing to disclose.
Terry Ann Glauser, MD, MPH, MCM Education VP, Medical Affairs, has nothing to disclose.
Faculty members are required to inform the audience when they are discussing off-label or unapproved uses of devices or drugs. Devices or drugs that are still undergoing clinical trials are identified as such and should not be portrayed as standard, accepted therapy. Please consult full prescribing information before using any product mentioned in this activity. If using products in an investigational, off-label manner, it is the responsibility of the prescribing physician to monitor the medical literature to determine recommended dosages and uses of the drugs. Neither the publisher nor the providers promote the use of any agent outside of approved labeling.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Chicago Pritzker School of Medicine and MCM Education. The University of Chicago Pritzker School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
CREDIT DESIGNATION STATEMENT
The University of Chicago Pritzker School of Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurses and other health care professionals will receive a Certificate of Participation. For information on the applicability and acceptance of Certificates of Participation for educational activities certified for AMA PRA Category 1 CreditTM from organizations accredited by the ACCME, please consult your professional licensing board.
Commercial Support Statements
This activity is supported by independent educational grants from AbbVie and Novartis.
- Computer Requirements: Minimum System Requirements: • Pentium III, 600 MHz or Equivalent Processor • 512 MB of RAM • Windows XP, Vista, or 7 • Mac OS X • 800x600 Monitor Resolution • 16-bit Color • 16 bit Sound Card with Speakers
- Accessing Activity:
* Click "Start Program"
* Take the pre-test
* Review the activity
* Take the post-test and score 80%
* You are allowed a total of 3 attempts
* Complete the evaluation
* View, print, or save a CME certificate verifying your credit/participation in this activity
There is no charge for CME credit.
©2017 MCM Education. All rights reserved. None of the contents may be reproduced in any form without prior written permission from the publisher. The opinions expressed in this educational activity are those of the faculty and do not necessarily reflect the opinions or recommendations of their affiliated institutions, the publisher, The University of Chicago Pritzker School of Medicine, AbbVie, or Novartis. Any medications, diagnostic procedures, or treatments discussed by the program presenters should not be used by clinicians or other health care professionals without first evaluating their patients' conditions, considering possible contraindications or risks, reviewing any applicable manufacturer’s product information, and comparing any therapeutic approach with the recommendations of other authorities.